A cost-benefit analysis of programmatic use of CVD 103-HgR live oral cholera vaccine in a high-risk population.

Cookson ST, Stamboulian D, Demonte J, Quero L, Martinez de Arquiza C, Aleman A, Lepetic A, Levine MM

Open source

DOI
10.1093/ije/26.1.212
Published
1997 Feb
Container
International journal of epidemiology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ije/26.1.212,
  title = {A cost-benefit analysis of programmatic use of CVD 103-HgR live oral cholera vaccine in a high-risk population.},
  author = {Cookson ST and Stamboulian D and Demonte J and Quero L and Martinez de Arquiza C and Aleman A and Lepetic A and Levine MM},
  year = {1997},
  journal = {International journal of epidemiology},
  doi = {10.1093/ije/26.1.212},
  url = {https://doi.org/10.1093/ije/26.1.212}
}

RIS

TY  - JOUR
TI  - A cost-benefit analysis of programmatic use of CVD 103-HgR live oral cholera vaccine in a high-risk population.
AU  - Cookson ST
AU  - Stamboulian D
AU  - Demonte J
AU  - Quero L
AU  - Martinez de Arquiza C
AU  - Aleman A
AU  - Lepetic A
AU  - Levine MM
PY  - 1997
JO  - International journal of epidemiology
DO  - 10.1093/ije/26.1.212
UR  - https://doi.org/10.1093/ije/26.1.212
ER  - 

APA

ST, C., D, S., J, D., L, Q., C, M. D. A., A, A., A, L., & MM, L. (1997). A cost-benefit analysis of programmatic use of CVD 103-HgR live oral cholera vaccine in a high-risk population.. International journal of epidemiology. https://doi.org/10.1093/ije/26.1.212

Source records